RCKT · ISSUER CIK 1281895
ROCKET PHARMACEUTICALS, INC.
Between Aug 1, 2026 and Oct 29, 2026, 5 ROCKET PHARMACEUTICALS, INC. insiders reported $0.00 of open-market purchases and $432K of sales on SEC Form 4.
↗5 insiders filed
Original Form 4 filings from Aug 1, 2026 to Oct 29, 2026. 0 of 7 sales were reported under a 10b5-1 plan.
$0.00Insider buying
$432KInsider selling
−$432KNet open-market
Sep 15, 2026Latest filing
| Ticker | Insider | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 15, 202620:27 | Sep 11, 2026 | RCKT | General Counsel | S · Sell | $3.40 | −75,364 | 598,489 | -11% | −$256K | ||
| Aug 20, 202617:30 | Aug 18, 2026 | RCKT | General Counsel | S · Sell | $3.38 | −631 | 673,853 | -0% | −$2K | ||
| Aug 20, 202617:25 | Aug 18, 2026 | RCKT | CEO | S · Sell | $3.38 | −2,293 | 1,056,594 | -0% | −$8K | ||
| Aug 17, 202617:52 | Aug 13, 2026 | RCKT | CEO | S · Sell | $3.38 | −2,837 | 1,058,887 | -0% | −$10K | ||
| Aug 17, 202617:50 | Aug 13, 2026 | RCKT | General Counsel | S · Sell | $3.38 | −3,493 | 674,484 | -1% | −$12K | ||
| Aug 13, 202616:15 | Aug 11, 2026 | RCKT | Chief Operating Officer | S · Sell | $3.50 | −36,658 | 505,784 | -7% | −$128K | ||
| Aug 13, 202616:15 | Aug 11, 2026 | RCKT | See Remarks | S · Sell | $3.50 | −4,701 | 262,809 | -2% | −$16K | ||
| Aug 5, 202620:49 | Aug 3, 2026 | RCKT | Chief Operating Officer | A · Grant | — | +73,313 | 542,442 | +16% | — | ||
| Aug 5, 202620:45 | Aug 3, 2026 | RCKT | Director | J · Other | — | +150,000 | 204,522 | +275% | — |